# MICAFUNGIN
> **NDA212156** · New Drug Application · Sponsor: PH HEALTH · Approved 2021-06-16
## Drug
- **FDA Application Number:** NDA212156
- **Application type:** New Drug Application
- **Brand name:** MICAFUNGIN
- **Generic name:** MICAFUNGIN
- **Active ingredients:** MICAFUNGIN SODIUM
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** PH HEALTH
- **Manufacturer:** Par Health USA, LLC
- **First approval:** 2021-06-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212156)
---
*MORVS · CC0 1.0*